HWM
HURA

HighMark Wealth Management’s TuHURA Biosciences HURA Stock Holding History

HighMark Wealth Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 561
2022
Q2 		$0 Buy
+1
New +$435 ﹤0.01% 547

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HighMark Wealth Management's HURA Position: Q3 2022 in Review

HighMark Wealth Management sold out of TuHURA Biosciences (HURA) in Q3 2022, closing a stake of 1 share.

HighMark Wealth Management first reported a position in HURA in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 24 funds tracked by Wall St. Rank hold HURA as of Q3 2022.

  • HighMark Wealth Management reported no remaining TuHURA Biosciences position as of Q3 2022 after selling out during the quarter.
  • HighMark Wealth Management sold 1 TuHURA Biosciences share in Q3 2022.
  • HighMark Wealth Management first reported a position in TuHURA Biosciences in Q2 2022 and held it in 1 quarter.
  • HighMark Wealth Management's TuHURA Biosciences position peaked at $0 in Q2 2022.
  • 24 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2022.

Based on HighMark Wealth Management's 13F filing for Q3 2022, filed 21 Oct 2022.